Migraine. Migraine
Conditions
Interventions
Intervention 1: The first intervention group: In this group, a Pregabalin oral capsule 50 mg or 75 (manufactured by Actoverco, Iran)mg was prescribed for weight of less than 30 kg and more than 30kg r
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
6 Years to 17 Years
Inclusion criteria
Inclusion criteria: Consent of parents and children over 13 years to participate in the study Boys and girls aged 6 to 17 years with migraine prophylaxis Migraine diagnosis based on the criteria of the International Headache Society, which includes cases of migraine without aura (5 attacks), migraine with aura (2 attacks), and each attack lasts 1 to 72 hours, and it is pulsating and severe, and accompanied by symptoms With nausea or vomiting, photophobia, phonophobia Not taking pregabalin and cinnarizine in the past
Exclusion criteria
Exclusion criteria: Drug Intolerance (symptoms such as diarrhea, nausea and vomiting) anaphylaxis severe dizziness excessive sleepiness
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Frequency of migraine headaches. Timepoint: The beginning of the study, 4, 8 and 12 weeks after the intervention. Method of measurement: Patient's history and notes. | — |
Secondary
| Measure | Time frame |
|---|---|
| Severity of migraine headaches. Timepoint: The beginning of the study, 4, 8 and 12 weeks after the intervention. Method of measurement: Based on the Visual Analogue Scale (VAS).;The rate of migraine attacks disability. Timepoint: The beginning of the study, 4, 8 and 12 weeks after the intervention. Method of measurement: Based on Pediatric Migraine Disability Assessment (PedMIDAS) tool. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammad Vafaeeshahi
Iran University of Medical Sciences
Outcome results
None listed